Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tezosentan for prevention of perioperative right ventricular failure in cardiac surgery patients with pre-operative pulmonary hypertension
2006-002907-15Phase 3Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pulmonary hypertension (PH) and Right heart dysfunction (RHF) comparing Tezosentan with Placebo (2 arms). Primary endpoint: Clinically relevant right ventricular failure during weaning from cardiopulmonary bypass. Started Jan 2007; status: completed.
02
Drugs
tezosentan
03
Conditions
pulmonary hypertension (PH)Right heart dysfunction (RHF)
Beyond the preview
Go deeper on 2006-002907-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002907-15.